John R. Vane
Impact in
- Biochemistry top 0.01%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 0.01%
- Inflammatory mediators and NSAID effects
Papers in
- Biochemistry 143
- Eicosanoids and Hypertension Pharmacology 139
- Pharmacology 170
- Inflammatory mediators and NSAID effects 149
- Co-authors
- Salvador MoncadaR M BottingChristoph ThiemermannRyszard J. GryglewskiJane A. MitchellS. H. FerreiraRegina M. BottingS Bunting
- Journals
- British Journal of Pharmacology (85 papers)Nature (39 papers)Proceedings of the National Academy of Sciences (28 papers)Journal of Cardiovascular Pharmacology (27 papers)Prostaglandins (26 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
John R. Vane
461 papers receiving 57.5k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Biochemistry 11.9k
- Pharmacology 24.7k
- Physiology 18.4k
- Cardiology and Cardiovascular Medicine 12.3k
- Pharmacology 4.5k
Countries citing papers authored by John R. Vane
This map shows the geographic impact of John R. Vane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Vane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Vane more than expected).
Fields of papers citing papers by John R. Vane
This network shows the impact of papers produced by John R. Vane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Vane. The network helps show where John R. Vane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John R. Vane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selective COX-2 inhibitors : pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France | 1998 | 3 |
| 2 | Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London | 1996 | 3 |
| 3 | The endothelial cell in health and disease | 1995 | 18 |
| 4 | 1994 | 67 | |
| 5 | Endothelin III : proceedings of the Third International Conference on Endothelin held at the Baylor College of Medicine, Houston, Texas, U.S.A., February 15-17, 1993 | 1993 | 1 |
| 6 | Therapeutic applications of prostaglandins | 1993 | 30 |
| 7 | 1993 | 157 | |
| 8 | Prostacyclin : new perspectives for basic research and novel therapeutic indications : proceedings of the Symposium on Novel Perspectives in Prostacyclin Research, Vienna, Austria, 25th September 1991 | 1992 | 1 |
| 9 | 1991 | 84 | |
| 10 | 1991 | 28 | |
| 11 | 1991 | 15 | |
| 12 | 1990 | 41 | |
| 13 | 1989 | 131 | |
| 14 | Pathways to new drugs. | 1985 | 1 |
| 15 | 1981 | 1 | |
| 16 | 1976 | 1 | |
| 17 | Proceedings: Inhibition of the pulmonary inactivation of prostaglandins in rabbit in vivo. | 1975 | 4 |
| 18 | Prostaglandin synthetase inhibitors : their effects on physiological functions and pathological states ; sponsored jointly by the Royal Society of Medicine Foundation, inc. of New York and the Royal Society of Medicine of London, held November 28-30, 1973 at the Rockefeller University, New York City | 1974 | 2 |
| 19 | 1971 | 6 | |
| 20 | 1961 | 4 |
About John R. Vane
John R. Vane is a scholar working on Biochemistry, Pharmacology, Physiology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 468 papers that have together received 63.3k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (176 papers), Inflammatory mediators and NSAID effects (149 papers), Eicosanoids and Hypertension Pharmacology (139 papers), Antiplatelet Therapy and Cardiovascular Diseases (44 papers), Renin-Angiotensin System Studies (43 papers), Receptor Mechanisms and Signaling (41 papers), Neuropeptides and Animal Physiology (37 papers) and Cardiac Ischemia and Reperfusion (32 papers). The work is most often cited by research in Biochemistry (11.9k citations), Pharmacology (24.7k citations), Physiology (18.4k citations), Cardiology and Cardiovascular Medicine (12.3k citations) and Pharmacology (4.5k citations). John R. Vane has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Salvador Moncada, R M Botting, Christoph Thiemermann, Ryszard J. Gryglewski, Jane A. Mitchell, S. H. Ferreira, Regina M. Botting, S Bunting, Timothy D. Warner and Y.S. Bakhle. Their work appears in journals such as British Journal of Pharmacology, Nature, Proceedings of the National Academy of Sciences, Journal of Cardiovascular Pharmacology and Prostaglandins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.